{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:46:45Z","timestamp":1790232405871,"version":"4.1.0"},"reference-count":20,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,11,15]]},"abstract":"<jats:p>Methotrexate (MTX) is a key compound of chemotherapeutic regimens used in the treatment of childhood acute lymphoblastic leukemia (ALL). Resistance to this drug may arise by, among other factors, altered cellular uptake that may hamper the efficacy of the treatment. Recently, a G80A polymorphism has been described in the reduced folate carrier gene (RFC1), which encodes the major MTX transporter. Here, we assessed the association between the genetic polymorphisms G80A and both MTX plasma levels and childhood ALL outcome. Children with the A80 variant had worse prognoses than patients with the GG genotype (P\u2009=\u2009.04), as shown by event-free survival estimates. Patients homozygous for A80 had higher levels of MTX (P\u2009=\u2009.004) than the other genotype groups. Possible explanations for observed associations are discussed; however, additional experiments are required to achieve understanding of the underlying mechanism.<\/jats:p>","DOI":"10.1182\/blood.v100.10.3832","type":"journal-article","created":{"date-parts":[[2002,10,30]],"date-time":"2002-10-30T14:43:16Z","timestamp":1035988996000},"page":"3832-3834","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":182,"title":["Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"100","author":[{"given":"Caroline","family":"Laverdie\u0300re","sequence":"first","affiliation":[{"name":"From the Centre de Recherche, Ho\u0302pital Sainte-Justine, Montre\u0301al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Chiasson","sequence":"additional","affiliation":[{"name":"From the Centre de Recherche, Ho\u0302pital Sainte-Justine, Montre\u0301al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Costea","sequence":"additional","affiliation":[{"name":"From the Centre de Recherche, Ho\u0302pital Sainte-Justine, Montre\u0301al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Moghrabi","sequence":"additional","affiliation":[{"name":"From the Centre de Recherche, Ho\u0302pital Sainte-Justine, Montre\u0301al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[{"name":"From the Centre de Recherche, Ho\u0302pital Sainte-Justine, Montre\u0301al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111821473271300_B1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00001622-200001000-00002","article-title":"Acute lymphoblastic leukemia in children.","volume":"12","author":"Pui","year":"2000","journal-title":"Curr Opin Oncol."},{"key":"2019111821473271300_B2","first-page":"83","article-title":"Biology and treatment of acute lymphocytic leukemia in children.","volume":"24","author":"Camitta","year":"1997","journal-title":"Semin Oncol."},{"key":"2019111821473271300_B3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","article-title":"Intrinsic and acquired resistance to methotrexate in acute leukemia.","volume":"335","author":"Gorlick","year":"1996","journal-title":"N Engl J Med."},{"key":"2019111821473271300_B4","first-page":"11","article-title":"Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.","volume":"26","author":"Sierra","year":"1999","journal-title":"Semin Oncol."},{"key":"2019111821473271300_B5","first-page":"2169","article-title":"Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.","volume":"4","author":"Zhang","year":"1998","journal-title":"Clin Cancer Res."},{"key":"2019111821473271300_B6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V89.3.1013","article-title":"Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.","volume":"89","author":"Gorlick","year":"1997","journal-title":"Blood."},{"key":"2019111821473271300_B7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<184::AID-IJC26>3.0.CO;2-I","article-title":"Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.","volume":"72","author":"Moscow","year":"1997","journal-title":"Int J Cancer."},{"key":"2019111821473271300_B8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V85.2.500.500","article-title":"Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.","volume":"85","author":"Matherly","year":"1995","journal-title":"Blood."},{"key":"2019111821473271300_B9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/mgme.2000.3034","article-title":"A polymorphism (80G\u2192A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia.","volume":"70","author":"Chango","year":"2000","journal-title":"Mol Genet Metab."},{"key":"2019111821473271300_B10","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1055\/s-2001-19739","article-title":"Polymorphisms in genes involved in folate metabolism as risk factors for NTDs.","volume":"11(suppl 1)","author":"De Marco","year":"2001","journal-title":"Eur J Pediatr Surg."},{"key":"2019111821473271300_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.10195","article-title":"Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.","volume":"108","author":"Shaw","year":"2002","journal-title":"Am J Med Genet."},{"key":"2019111821473271300_B12","first-page":"828","article-title":"Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.","volume":"51","author":"Refsum","year":"1991","journal-title":"Cancer Res."},{"key":"2019111821473271300_B13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0145-2126(99)00181-2","article-title":"Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables.","volume":"24","author":"Seidel","year":"2000","journal-title":"Leuk Res."},{"key":"2019111821473271300_B14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2401980","article-title":"Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995).","volume":"14","author":"Silverman","year":"2000","journal-title":"Leukemia."},{"key":"2019111821473271300_B15","first-page":"802","article-title":"Polymorphisms in genes encoding drugs and xenobiotic metabolizing, DNA repair enzymes, and response to treatment in children with acute lymphoblastic leukemia.","volume":"8","author":"Krajinovic","year":"2002","journal-title":"Clin Cancer Res."},{"key":"2019111821473271300_B16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/abio.1999.4293","article-title":"Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay.","volume":"275","author":"Labuda","year":"1999","journal-title":"Anal Biochem."},{"key":"2019111821473271300_B17","first-page":"3416","article-title":"Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G\/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.","volume":"7","author":"Whetstine","year":"2001","journal-title":"Clin Cancer Res."},{"key":"2019111821473271300_B18","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.1074\/jbc.273.46.30189","article-title":"A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.","volume":"273","author":"Jansen","year":"1998","journal-title":"J Biol Chem."},{"key":"2019111821473271300_B19","doi-asserted-by":"crossref","first-page":"30855","DOI":"10.1074\/jbc.M003988200","article-title":"Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.","volume":"275","author":"Drori","year":"2000","journal-title":"J Biol Chem."},{"key":"2019111821473271300_B20","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","article-title":"Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.","volume":"92","author":"Balis","year":"1998","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/10\/3832\/1252040\/h82202003832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/10\/3832\/1252040\/h82202003832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T21:47:46Z","timestamp":1574113666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/10\/3832\/106265\/Polymorphism-G80A-in-the-reduced-folate-carrier"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,15]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v100.10.3832","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11,15]]}}}